This paper is only available as a PDF. To read, Please Download here.
This paper is a report of the treatment of pulmonary tuberculosis by cortisone combined with standard chemotherapy. The clinical, bacteriological and radiological findings are presented in nineteen patients. Cortisone can be safely administered to the tuberculous subject if it is covered by anti-tuberculous chemotherapy. Symptomatic improvement is commonly observed and weight gain is largely permanent. Eleven of nineteen patients were considered to have shown accelerated improvement with cortisone and the best results occurred in relatively acute lesions.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Respiratory Medicine
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Edinb. med. J. 1954; 61: 238
- Lancet. 1953; 1: 808
- Amer. Rev. Tuberc. 1951; 64: 564
- J. Amer. med. Ass. 1951; 147: 242
- Lancet. 1950; 2: 381
- Lancet. 1954; 1: 595
- J. Amer. med. Ass. 1951; 147: 238
- J. clin. Invest. 1951; 30: 445
- Proc. Soc. exp. Biol. (NY). 75. 1950: 613
- J. Amer. med. Ass. 1951; 147: 241
- J. clin. Invest. 1950; 29: 849
- U.S. Veterans Admin. Quart. Progress Report. October, 1950; : 23
Received: November 18, 1955
© 1956 Baillière, Tindall & Cox, Ltd. Published by Elsevier Inc.